Xconomy | Boston - Business + Technology in the Exponential Economy

EnVivo Pharmaceuticals, Inc. Garners $65,000,000 New Financing Round

  • Feed Type
  • Date
    10/31/2008
  • Company Name
    EnVivo Pharmaceuticals, Inc.
  • Mailing Address
    480 Arsenal Street, Building 1 Watertown, MA 02472
  • Company Description
    EnVivo is a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system (CNS) disorders. CNS disorders account for more hospitalizations, long-term care, and chronic suffering than nearly all other diseases combined.
  • Website
    http://www.envivopharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $65,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Fidelity BioSciences

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.